Friday, November 6, 2026

Post Q3 EVC Update

EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.

EVC $832M

Nat Stewart - Stock Picking Newsletter Nov 6 26 clicks

Nov 6 CRWV $27B

The Midterms Have Changed the AI Narrative: S&P Down 4.4%, Nasdaq Down 5.5% | The Weekly Wrap

Steve Eisman 5 clicks

Nov 6 OVV $17B

Oil & Gas M&A Boom Continues with Another Billion-Dollar Oil Buyout

Bison Insights 4 clicks

From X

@majgeoinvesting Aug 11

Maj Soueidan on X

Can’t say there’s any slam dunk information arbitrage out of @InfoArbMonitor last batch of Delta Sheets, but there’s still a few interesting tid bits. $ASYS and $PAYS are not crazy cheap, but could be on future numbers. $NNBR probably has the best momentum, but they just went through some massive dilution. $ASYS might be my favorite out of the bunch. Thinking about buying it back at some point.

@ChrisCamillo Aug 11 1 click

Chris Camillo on X

@eager28 No I’m invested indirectly via $SKM

@HaydenCapital Aug 11 1 click

Fred Liu on X

I think $MELI's up for same reason $SE's up. Signs that Sea's reinvestment cycle is turning (or least not as aggressive as feared - see the 2H ebitda guide), which means less pressure on MELI. And maybe MELI margins have found a bottom / will inflect soon too. + Just maybe, both can co-exist & grow 50% y/y.

@TheBenSchmark Aug 11 1 click

JabroniCoin.USD on X

For FY 2027, the Company expects net sales in the range of $65.0 billion to $72.0 billion. Net sales in the range of $14.5 billion & $15.5 billion for the first quarter of FY 2027 ending September, 2026, and non-GAAP net income per diluted share of $1.01 to $1.10 $SMCI 👀

@majgeoinvesting Aug 11

Maj Soueidan on X

Just finished going over the $BWEN Q2 earnings script. There might be a glimmer of hope it to keep it interesting in the short term: •Unfortunately, 19% EBITDA industrial segment margins will “fall to more normal levels.” For the last three years, that’s ranged between 11 and 15%. However, revenue will be above historical levels. •Backlog is exceptionally strong, with visibility out to 2028. These guys have never had that kind of visibility. •It looks like a chance for profitability comes from me two scenarios. 1). Aggressively growing the industrial segment because it doesn’t look like margin expansion will occur. 2). The gearing segment EBITDA margins have been historically low, under 10%. So an expansion there, while also getting revenue growth might be interesting. •As far as acquisitions go, I’m not holding out for them finding a great deal. You have to think that valuations will be extended. I would actually prefer them to take their time, by being patient and growing organically - filling some of the available capacity they have right now. •In the end, it’s all about margins for these guys. They really have had a hard time keeping them stable.

@AsifSuria Aug 11

Asif Suria on X

I am more interested in $FICO at its current price than when we wrote about the company last month in a Stock Buyback Wednesdays article. The company was trading at a little over $1,300 and we concluded the article as follows:

@Mike10947310 Aug 11 1 click

Mike on X

@kingtutcap I know $VELO well any others to look at? Maybe something involved in missile production?

@irbezek Aug 11 1 click

Ian Bezek on X

@shortbus_ace @akeemcap @QuietProsperity $CAAP is 6x EV/EBITDA and no Mexico. But half of EBITDA is from Argentina, so that's its own can of worms (albeit the Argy fees are charged at a fixed USD rate not Peso)

Entravision Q3 Update

Entravision’s Q3 ad-tech revenue reached $177.2 million, up 133% year over year, while total revenue rose 88% to $226.3 million and diluted…

EVC $832M

The Value Road Nov 6 4 clicks

(Idea) Transocean - Near-Term Results Obscure A Brighter Future

Transocean’s 25.6% selloff reflects oil-market shorting and weak Q3 headlines, while debt reduction after the Valaris acquisition could…

RIG $5.8B

HFI Research Nov 6 6 clicks

Axon 3Q26 Business Update

Axon cut full-year guidance after delayed federal Dedrone contracts slowed 3Q revenue growth to 28%, while software and services grew 43%.

AXON $31B

Speedwell Memos Nov 6 4 clicks

Axon 3Q26 Update: Revenue Breaks Below 30%, Runway Reaffirmed

Axon’s 3Q26 revenue growth fell to 28% after delayed federal Dedrone contracts, while software grew 43% and its $1.2 billion Skydio…

AXON $31B

Speedwell Research Nov 6 4 clicks

CareCloud (CCLD): A Second Sales Rep Talks. More Structure. Didn’t have a leader of sales for 18 months. That has changed. Organic growth through Medsphere?

CareCloud rebuilt its sales organization under Christopher Langehaug after 18 months without a sales leader, with a second sales rep…

CCLD $107M

Calvin Blissett Nov 6 7 clicks

Datadog (NASDAQ: DDOG) Stock Rating: Stop After Q3 FY12/26 Earnings

Datadog beat Q3 revenue guidance by $52 million, but guided Q4 revenue flat as its largest AI-native customer reduced usage after renewing.

DDOG $65B

Cestrian Capital Research Nov 6 1 click

Alpha Metallurgical Resources (AMR): Q3 2026 Earnings

Alpha Metallurgical posted a third consecutive quarterly loss as High Vol A coal margins fell to $14 a ton, while director Kenneth Courtis…

AMR $1.9BHCC $4.4B

Cannibal Stocks Nov 6 3 clicks

A clear solution to the “problem”

Shift4’s Q3 met guidance, but organic growth is decelerating, management credibility is weakening and leverage reduction remains too slow.

FOUR $3.4B

Best Anchor Stocks Nov 6 2 clicks

GREAT DEC-TECTIVE WORK

Diversified Energy reported $255.6 million of “true” nine-month free cash flow, while its $1.8 billion Birch acquisition would shift…

DEC $900M

The Oak Bloke Nov 6 4 clicks

Cloudflare (NET) Q3 FY12/26 Earnings Review

Cloudflare’s Q3 revenue rose 39% to $782.5 million, its fastest growth in nearly four years, while a $67.9 million GAAP operating loss and…

NET $97B

Cestrian Capital Research Nov 6 1 click

Dynatrace (NYSE: DT) Stock Rating: Do Nothing After Q2 FY3/27 Earnings (No Paywall)

Dynatrace reported 17% Q2 revenue growth but flat new ARR and lower profit and free-cash-flow guidance, following its $816 million Arize…

DT $13B

Cestrian Capital Research Nov 6 3 clicks

Coherent: Selling Volume While Lumentum Sells Scarcity

Coherent sells constrained InP capacity through volume-priced modules, while a $20 billion PhotonLink agreement marks its first…

COHR $38BLITE $48B

Keyanoush Razavidinani Nov 6 4 clicks

CareCloud (CCLD): Q3 2026 Call Notes and Thesis. My biggest position, I’m bullish. To me it’s a multibagger

CareCloud’s Q3 revenue rose 9% through acquisitions but fell 8% pro forma; the RCM consolidator targets 25–30% margins by shifting acquired…

CCLD $107M

Calvin Blissett Nov 6 2 clicks

Reddit Stock $RDDT : The Human Internet Just Got 29% Cheaper

Reddit fell 29% after warning that Google search traffic was declining, despite Q3 revenue rising 53%; the bull case rests on communities,…

RDDT $18B

Substack von Philipp Nov 6 4 clicks

Rocket Lab: Less Euphoria, Still Too Much Perfection Priced In Ahead Of Q3

Rocket Lab faces Neutron delays, Iridium acquisition dilution and cash burn despite expected 66% Q3 revenue growth, leaving RKLB priced for…

RKLB $28B

Bernard Zambonin Nov 6 1 click

Marvell Buys Lumentum: MRVL Initiated at Buy, $258 PT

Marvell’s Lumentum acquisition targets optical networking demand as AI data centers shift from copper to lasers, expanding its hyperscaler…

LITE $48B

Monte Independent Investment Research Nov 6 2 clicks

Blue Owl Capital: Book Value Is Rising Under A Default-Wave Price

Blue Owl Capital's NAV rose to $14.32 as buybacks and portfolio marks improved, while OBDC trades at a 25% discount despite a 0.33%…

OWL $16B

Tim Travis Nov 6 1 click

AAP · long

Advance Auto Parts INC

Advance Auto Parts, AAP, is presented as a long idea following prior write-ups at $48.81 per share in January 2025.

AAP $2.9B

Value Investors Club Aug 8 2 clicks

Artiva Biotherapeutics: Busted Biotech

ARTV $206M

Clark Street Value Nov 5 5 clicks

TransMedics Group Inc Earnings Update: Q3 2026

TransMedics reported record Q3 2026 revenue exceeding $200 million, driven by its organ transplant technology business.

TMDX $3.1B

SixSigmaCapital: Navigating the Financial Markets Nov 5 5 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

YouTube 4

Blogs 15

Seeking Alpha 77 of 281

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Nominate an account

Investor letters we follow

360 firms

Sectors

Ordered by how often our editor reaches for them.

Friday, November 6, 2026

Maj Soueidan on X

Chris Camillo on X

Fred Liu on X

JabroniCoin.USD on X

Maj Soueidan on X

Asif Suria on X

Mike on X

Ian Bezek on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 77 of 281

X accounts we follow

Investor letters we follow

Sectors